LUBYX | MAFRX | LUBYX / MAFRX | |
Total Expense Ratio | 0.28 | 0.60 | 47% |
Annual Report Gross Expense Ratio | 0.28 | 0.60 | 47% |
Fund Existence | 9 years | 14 years | - |
Gain YTD | 2.415 | 2.499 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.4B | 7.81B | 172% |
Annual Yield % from dividends | 4.94 | 5.36 | 92% |
Returns for 1 year | 5.51 | 5.52 | 100% |
Returns for 3 years | 16.64 | 19.01 | 88% |
Returns for 5 years | 15.80 | 21.85 | 72% |
Returns for 10 years | N/A | 28.99 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BDBPX | 24.69 | 0.25 | +1.02% |
iShares Russell 2000 Small-Cap Idx Inv P | |||
ICTEX | 16.69 | 0.11 | +0.66% |
ICON Health and Information Tech Instl | |||
JBALX | 49.13 | 0.27 | +0.55% |
Janus Henderson Balanced I | |||
MWOIX | 67.54 | 0.35 | +0.52% |
MFS Global Growth I | |||
LINVX | 22.74 | 0.04 | +0.18% |
Lord Abbett International Opp R6 |